✦ LIBER ✦

Immunosuppression: towards a logical approach in liver transplantation

✍ Scribed by I. Perry; J. Neuberger

Book ID: 108699048
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 150 KB
Volume: 139
Category: Article
ISSN: 0009-9104
DOI: 10.1111/j.1365-2249.2005.02662.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunosuppression in liver transplantati

Immunosuppression in liver transplantation

✍ David J. Post; David D. Douglas; David C. Mulligan 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB

E arly mythology depicts two saints in a life-and- death struggle to save a limb from a foregone fate. Saints Cosmos and Damien replaced a cancerous leg with a limb from a deceased Moor. This illustration was mere fantasy until the latter part of the previous century with the seminal surgeries perfo

Immunosuppression in liver transplantati

Immunosuppression in liver transplantation: Beyond calcineurin inhibitors

✍ John Fung; Dympna Kelly; Zakiyah Kadry; Kusum Patel-Tom; Bijan Eghtesad 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB

Although calcineurin inhibitors (CNIs) remain the mainstay of immunosuppression in liver transplantation (LTX), their long-term toxicity significantly contributes to morbidity and mortality. The elucidation of mechanisms of alloimmunity and leukocyte migration have provided novel targets for immunos

Future prospects in immunosuppression fo

Future prospects in immunosuppression for liver transplantation

✍ John J. Fung; Jessica E. Bollinger; Charles Miller; Bijan Eghtesad 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

## Key Points 1. Our increasing understanding of signaling pathways and cellular interactions in transplant immunobiology and the availability of novel immunosuppressive agents have facilitated targeted strategies. 2. The driving forces behind the development of new immunosuppressive regimens are t

Immunosuppression strategies after liver

Immunosuppression strategies after liver transplantation: a single centre experience in 57 liver transplant recipients

✍ Rajeev Sharma; M. R. Rajasekar; Arun Raghuvanshi 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 61 KB

Immunosuppression in pediatric liver tra

Immunosuppression in pediatric liver transplantation: Are little people different?

✍ Anil Dhawan 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

The pediatric population has many physiological differences that can significantly alter the pharmacokinetic and pharmacogenomic disposition in terms of Abbreviations: EBV, Epstein-Barr virus; LT, liver transplantation; MMF, mycophenolate mofetil. Potential conflict of interest: Unrestricted educat

Induction immunosuppression with rabbit

Induction immunosuppression with rabbit antithymocyte globulin in pediatric liver transplantation

✍ Ashesh Shah; Avinash Agarwal; Richard Mangus; Joel Lim; Jonathan Fridell; Rodrig 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

Routine use of rabbit antithymocyte globulin (RATG) induction therapy remains controversial in pediatric liver transplantation. We reviewed our experience of 18 cadaveric liver transplants in 18 children over a span of 2 years. All patients received the same immunosuppression: perioperative steroid